QSC Tirzepatide (CAS 6893-02-3) is a high purity pharmaceutical compound developed for research purposes. This white powder exhibits dual agonist activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Our QSC tirzepatide demonstrates superior efficacy in glucose control compared to selective GLP-1 receptor agonists. The compound mimics natural GIP actions at the GIP receptor, making it valuable for metabolic disorder research.
The product is supplied as lyophilized powder with purity ≥99%. Proper storage in cool, dry conditions away from strong light is recommended to maintain stability. For research use only.
QSC tirzepatide represents an important advancement in diabetes research compounds. Its dual mechanism of action offers researchers new possibilities for studying metabolic regulation pathways.